The global demand for Seasonal Influenza Vaccines Therapeutics Market is presumed to reach the market size of nearly USD 15.98 BN by 2028 from USD 8.2 BN in 2021 with a CAGR of 10% under the study period 2022 - 2028.
Seasonal Influenza Vaccines Therapeutics refers to products which are used for the prevention & treatment of seasonal influenza, a highly contagious respiratory illness caused by the influenza virus. Seasonal influenza vaccines are used for the prevention of the flu, while therapeutics are used for the treatment of the flu once it has been contracted. Seasonal influenza vaccines come in several forms, including inactivated vaccines, live attenuated vaccines, and recombinant vaccines. Inactivated vaccines contain dead virus particles, while live attenuated vaccines contain weakened virus particles. Recombinant vaccines contain only a portion of the virus's genetic material. Therapeutics for seasonal influenza include antiviral drugs, which can reduce the severity and duration of symptoms, and improve the overall prognosis of the disease. These drugs can be administered orally or intravenously, and they work by inhibiting the replication of the virus. Seasonal influenza vaccines and therapeutics play a critical role in protecting individuals from the flu and reducing the incidence of the disease.
Market Dynamics
The increasing incidence of seasonal influenza, and the growing awareness about the importance of vaccination for the prevention of seasonal influenza are driving the demand for seasonal influenza vaccines. With increased awareness, more people are seeking vaccination, adding to the market demand. The development of advanced seasonal influenza vaccines and therapeutics, such as quadrivalent vaccines and antiviral drugs, is driving the growth of the market. These advancements have improved the safety and efficacy of the vaccines and treatments, making them more attractive to patients and healthcare providers. Government initiatives aimed at promoting vaccination and improving access to vaccines and treatments are driving the growth of the market. These initiatives include vaccine mandates, subsidies for vaccine purchases, and public education campaigns about the importance of vaccination. The growing geriatric population, who are more vulnerable to the flu, is driving the demand for seasonal influenza vaccines and therapeutics.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of seasonal influenza vaccines therapeutics. The growth and trends of seasonal influenza vaccines therapeutics industry provide a holistic approach to this study.
Market Segmentation
This section of the seasonal influenza vaccines therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Paediatrics
- Adolescence
- Adults
- Elderly
By Application
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Seasonal Influenza Vaccines Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Seasonal Influenza Vaccines Therapeutics Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the seasonal influenza vaccines therapeutics market include Novartis AG, AstraZeneca, Hualan Biological Engineering Inc., CSL Limited, GlaxoSmithKline plc, Sanofi, Sinovac Biotech Ltd., Protein Sciences, MERCK & CO., INC., and Serum Institute of India Pvt. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.